Clinical practice. Hirsutism.

[1]  R. Azziz.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal. , 2005, Fertility and sterility.

[2]  A. Hermann,et al.  Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  D. Ehrmann.  Polycystic ovary syndrome. , 2004, The New England journal of medicine.

[4]  R. Rosenfield,et al.  Polycystic Ovary Syndrome in Adolescence , 2002 .

[5]  R. Azziz,et al.  The prevalence of androgen excess among patients with minimal unwanted hair growth. , 2004, American journal of obstetrics and gynecology.

[6]  E. Battle,et al.  Laser‐assisted hair removal for darker skin types , 2004, Dermatologic therapy.

[7]  M. Quinkler,et al.  Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. , 2004, The Journal of endocrinology.

[8]  D. Schoenfeld,et al.  Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  J. Wood,et al.  Valproate potentiates androgen biosynthesis in human ovarian theca cells. , 2004, Endocrinology.

[10]  K. Taylor,et al.  Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  W. Vloten,et al.  Selecting an Oral Contraceptive Agent for the Treatment of Acne in Women , 2004, American journal of clinical dermatology.

[12]  D. Petitti.  Combination Estrogen–Progestin Oral Contraceptives , 2003 .

[13]  J. Taieb,et al.  Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. , 2003, Clinical chemistry.

[14]  S. Chew,et al.  The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  N. Sattar,et al.  Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome , 2003, The Lancet.

[16]  R. Azziz.  The evaluation and management of hirsutism. , 2003, Obstetrics and gynecology.

[17]  C. Dierickx.  Hair removal by lasers and intense pulsed light sources. , 2002, Dermatologic clinics.

[18]  R Krattenmacher,et al.  Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. , 2000, Contraception.

[19]  A. Latronico,et al.  Adrenocortical carcinoma , 2000, Cancer.

[20]  D. Driscoll,et al.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Ehrmann,et al.  Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.

[22]  J. Clore,et al.  A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[23]  W. Rosner,et al.  The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. , 1990, Endocrine reviews.

[24]  R. Rittmaster,et al.  Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women. , 1988, The Journal of clinical endocrinology and metabolism.

[25]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[26]  S. Marynick,et al.  Androgen excess in cystic acne. , 1983, The New England journal of medicine.

[27]  G. W. Moll,et al.  Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. , 1979, The Journal of clinical endocrinology and metabolism.

[28]  R. Rosenfield.  Plasma free androgen patterns in hirsute women and their diagnostic implications. , 1979, The American journal of medicine.

[29]  M. Levell,et al.  THE USE OF OESTROGEN/PROGESTOGEN PREPARATIONS IN THE TREATMENT OF HIRSUTISM IN THE FEMALE , 1974, The Journal of obstetrics and gynaecology of the British Commonwealth.

[30]  R. Rosenfield,et al.  Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. , 1971, The Journal of clinical endocrinology and metabolism.